APHM Hopital Timone

Marseille 13385

0 studies enrolling now · 4 studies all time

What they study most

Adenomatous Polyposis Coli, Prostatic Neoplasms, Urothelial Carcinoma

Studies at this site

• A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer — Running, not enrolling
• A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer — Running, not enrolling
• A Study of Guselkumab in Participants With Familial Adenomatous Polyposis — Completed
• A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis — Completed